# Study on Cognitive Disorders of Multiple Sclerosis

> **NCT01074619** · PHASE3 · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 90 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Memantine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01074619
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-11
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2012-09-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01074619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01074619, "Study on Cognitive Disorders of Multiple Sclerosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01074619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*